Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy

por Kanikarla-Marie, Preeti, Lam, Michael, Sorokin, Alexey V., Overman, Michael J., Kopetz, Scott, Menter, David G.
Publicado 2018

The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress

por Kim, Ekaterina R, Selyutina, Anastasia A, Buldakov, Ilya A, Evdokimova, Valentina, Ovchinnikov, Lev P, Sorokin, Alexey V
Publicado 2013

YB-1 Phosphorylation at Serine 209 Inhibits Its Nuclear Translocation

por Sogorina, Ekaterina M., Kim, Ekaterina R., Sorokin, Alexey V., Lyabin, Dmitry N., Ovchinnikov, Lev P., Mordovkina, Daria A., Eliseeva, Irina A.
Publicado 2021

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

por Sorokin, Alexey V., Kanikarla Marie, Preeti, Bitner, Lea, Syed, Muddassir, Woods, Melanie, Manyam, Ganiraju, Kwong, Lawrence N., Johnson, Benny, Morris, Van K., Jones, Philip, Menter, David G., Lee, Michael S., Kopetz, Scott
Publicado 2022

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts

por Kanikarla Marie, Preeti, Sorokin, Alexey V., Bitner, Lea A., Aden, Rebecca, Lam, Michael, Manyam, Ganiraju, Woods, Melanie N., Anderson, Amanda, Capasso, Anna, Fowlkes, Natalie, Overman, Michael J., Menter, David G., Kopetz, Scott
Publicado 2022